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Abstract
Background: There has been increased interest in recent years in very low carbohydrate ketogenic diets (VLCKD)
that, even though they are much discussed and often opposed, have undoubtedly been shown to be effective, at
least in the short to medium term, as a tool to tackle obesity, hyperlipidemia and some cardiovascular risk factors.
For this reason the ketogenic diet represents an interesting option but unfortunately suffers from a low
compliance. The aim of this pilot study is to ascertain the safety and effects of a modified ketogenic diet that
utilizes ingredients which are low in carbohydrates but are formulated to simulate its aspect and taste and also
contain phytoextracts to add beneficial effects of important vegetable components.
Methods: The study group consisted of 106 Rome council employees with a body mass index of ≥ 25, age
between 18 and 65 years (19 male and 87 female; mean age 48.49 ± 10.3). We investigated the effects of a
modified ketogenic diet based on green vegetables, olive oil, fish and meat plus dishes composed of high quality
protein and virtually zero carbohydrate but which mimic their taste, with the addition of some herbal extracts
(KEMEPHY ketogenic Mediterranean with phytoextracts). Calories in the diet were unlimited. Measurements were
taken before and after 6 weeks of diet.
Results: There were no significant changes in BUN, ALT, AST, GGT and blood creatinine. We detected a significant
(p < 0.0001) reduction in BMI (31.45 Kg/m
2 to 29.01 Kg/m
2), body weight (86.15 kg to 79.43 Kg), percentage of fat
mass (41.24% to 34.99%), waist circumference (106.56 cm to 97.10 cm), total cholesterol (204 mg/dl to 181 mg/dl),
LDLc (150 mg/dl to 136 mg/dl), triglycerides (119 mg/dl to 93 mg/dl) and blood glucose (96 mg/dl to 91 mg/dl).
There was a significant (p < 0.0001) increase in HDLc (46 mg/dl to 52 mg/dl).
Conclusions: The KEMEPHY diet lead to weight reduction, improvements in cardiovascular risk markers, reduction
in waist circumference and showed good compliance.
Background
Obesity has become a health emergency in Western
countries [1,2]. As is well known, obesity and in particu-
lar abdominal obesity is one of the principle risk factors
for cardiovascular disease and along with dyslipidemia,
hypertension and diabetes contributes to the metabolic
syndrome [3]. Even though weight loss is a desired goal
for most overweight individuals, and its health benefits
have been clearly determined [4,5], there are still no
definitive data on what dietary protocols are most effec-
tive in both the short and long term [6] or even what is
the correct nutritional approach in general [7].
The most commonly accepted dietary strategy is based
on relatively high levels of carbohydrates and low fat
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diets yield only modest weight loss and suffer from low
long-term compliance [8]. In fact adherence of over-
weight/obese individuals to high carbohydrate/low fat
nutrition is often a problem because the majority have
been shown to have dietary preferences for foods with a
rich fat content. Furthermore rather than consume com-
plex carbohydrates there is a tendency to prefer highly
processed food containing simple sugars [9-11] such
that a low fat diet can actually encourage the consump-
tion of sugars and refined carbohydrates that can wor-
sen weight problems and also facilitate dyslipidemia
especially in insulin resistance individuals [12,13]. As a
consequence of the relative inefficacy of these types of
diet there has been increased interest in recent years in
very low carbohydrate ketogenic diets (VLCKD) [14]
that, have undoubtedly been shown to be effective, at
l e a s ti nt h es h o r tt om e d i u mt e r m ,a sat o o lt ot a c k l e
obesity, hyperlipidemia and some cardiovascular risk
factors [15-18]. The Mediterranean diet is often pro-
posed as the healthy standard but many of the advan-
tages associated with it can actually be linked to life
style and the true original Mediterranean diet did not
contemplate the current high levels of refined carbohy-
drates on which the typical Italian diet is based [19,20].
For this reason the standard ketogenic diet is not asso-
ciated with high compliance in populations, like the Ita-
lian, that are used to carbohydrate based diets. The
objective of the present study, which was devised as a
case pilot trial, is to assess the safety, compliance and
effects of a “Mediterranean style” ketogenic diet that uti-
lizes very low carbohydrate ingredients formulated to
simulate the aspect and taste of common carbohydrate
rich foods (e.g. pasta) and which contain phytoextracts
intended to add beneficial effects of important vegetable
components. The aim of using herbal extracts during
the diet period was to reduce some commonly reported
light side effects of ketogenic diets. The parameters
measured include blood biomarkers, body composition,
weight loss and compliance in a cohort of council
employees in Rome, Italy.
Methods
Subjects
The pilot study group consisted of 106 Rome council
employees (19 males and 87 female; mean age 48, 49 ±
10, 33). Inclusion criteria were: BMI ≥ 25, age > 18
years and < 65 years, currently on a carbohydrate rich
diet (> 50% energy), [21] desire to lose weight and
health status suitable for a modified ketogenic diet
(Tisanoreica
®) [22] i.e. normal renal function, not preg-
nant or lactating. After the start of the experimental
protocol the subjects who began new exercise programs
or pharmaceutical treatments would be excluded. A
small rise in transaminase was not considered a condi-
tion for exclusion since mild alterations in GOT and
GPT values are common in obese individuals. Subjects
eligible for the study were invited to the IPA clinic (Isti-
tuto di Previdenza ed Assistenza - health services for
public sector employees) to attend an orientation ses-
sion. At the first visit it was explained that during the
first three weeks it was necessary to almost totally
exclude carbohydrates and a detailed menu containing
permitted and non-permitted foods was provided to
each participant, along with the components of the
ketogenic Mediterranean with phytoextracts (KEME-
PHY) diet described below. Anthropometric measures
were performed and blood samples were taken from the
subjects two-three days before and after they began the
diet. Subjects received no monetary compensation for
their participation and signed a voluntary consent form
before initiating the diet. The ethical and clinical review
committee of IPA and the European Nutrition Society
approved the study protocol, informed consent form
and information material provided to subjects.
Diet
The KEMEPHY (ketogenic Mediterranean with phytoex-
tracts) diet protocol was ketogenic during the first 3
weeks with approximately 34 g of CHO daily, using low
carbohydrate high-protein meals and herbal teas [22]
(Tisanoreica
® by Gianluca Mech SpA, Orgiano VI)
(Table 1 and 2).
The permitted foods were: cooked or raw green vege-
tables (200 g/meal), meat, fish and eggs (2 times/day),
olive oil 40 g/day. Integration with a dish (PAT
® i.e.
porzione alimentare tisanoreica = tisanoreica nutritional
portion) composed of high quality proteins (equivalent
to 18 grams) and virtually zero carbohydrate (but that
mimic their taste) was provided for every meal, for a
maximum of four PATs per day. During the last three
weeks complex carbohydrates were introduced (50-80 g/
day), cheese (60 g/day), PAT was reduced from four to
two, while the other indications remained unchanged.
The distribution of nutrients (proteins, carbohydrates
and fats) in terms of percentage of total caloric intake
was 36%, 12% and 52%, respectively (weeks 1 to 3) and
31%, 25% and 44% (weeks 4 to 6). During the 6 weeks,
the patients in the study group consumed 20 ml of
extract A, 20 ml of extract B and 50 ml of extract C.
During the first two weeks, before breakfast and lunch,
they also consumed 40 ml of extract D (Tables 2 and 3).
Supplements
Subjects also took a daily (1 caplet each morning) multi-
vitamin supplement [23] (containing Magnesium19 mg,
Calcium 16 mg, Phosphorus 8 mg, Zinc 4.5 mg, Iron
4.62 mg, Manganese 1 mg, Potassium 0.5 mg, Copper
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mg, Beta carotene 1.8 mg, Folic Acid 66 μg, Biotin 30
μg, Vitamin C 19.8 mg, Vitamin E 3.3 mg, Pantothenic
Acid 1.98 mg, Vitamin B6 0.66 mg, Vitamin B2 0.53 mg,
Vitamin B1 0.426 mg, Vitamin D3 1.65 μg, Vitamin B12
0.33 μg (Multivitaminico Balestra e Mech, Gianluca
Mech SpA, Orgiano VI).
Measurements
Subjects were weighed at the same time of day at the
start and after 6 weeks of the diet, using the same
weighing scales (Digital Scale Joycare
® Jc431). Fasting
venous blood samples were collected at weeks 0 and 6
for total cholesterol (CHOLt), triacyglicerol (TG) high-
density lipoprotein cholesterol (HDLc), low-density lipo-
protein cholesterol (LDLc), glucose, blood urea nitrogen
(BUN), uricemia, VES, creatinine, ALT, AST, GGT.
Blood was collected in EDTA treated vacutainer tubes.
To avoid interassay variation all blood samples were
stored at -80° and analysed together at the end of the
study. A separate sample of blood was clotted and
serum analyzed for total cholesterol and triacylglycerols
by photometric assay with an intra-assay and interassay
CV values of 2% and 4%, respectively.
HDL cholesterol was determined using a homoge-
nous enzyme immunoassay. The intra-assay and inter-
assay CV values were both < 4%. Plasma glucose was
determined colorimetrically using glucose oxidase
methodology. Plasma urea nitrogen were measured
using an enzymatic (urease), colorimetric method.
Creatinine was measured colorimetrically using the
picric acid assay, and uric acid was determined using a
modified Trinder peroxide assay. LDLc fraction was
calculated from Friedewald’sf o r m u l a :L D L c=T C-
HDLc - (TG/5) [24]. Body composition was assessed
using bioelectrical impedance analysis (BIA Akern
Bioresearch, Pontassieve, FI, Italy) which is a non-inva-
sive and portable method for the estimation of fluid
compartments, fat and fat-free mass in healthy sub-
jects. Bioelectrical impedance analysis was chosen for
the analysis of body composition due to its reliability,
safety, convenience and non-invasiveness making it
optimal for the routine monitoring of body composi-
tion during the ketogenic diet [25,26]. The experimen-
tal design is showed in Figure 1.
Statistical analysis
We tested the normality and the assumption of homo-
scedasticity of all parameters at the start of the trial
using the Kolmogorov-Sminorv and Shapiro-Wilk tests.
To study changes over time and the effects of gender,
we added an appropriate interaction analysis. As there
were no significant gender interactions, the data of each
group were pooled and analyzed together. A Student’st
test was used to compare parameters before and after 6
weeks of the KEMEPHY diet using Statistica Software,
ver. 8.0 (Tulsa, USA) and the software package Graph-
Pad Prism version 4.00 for Windows, GraphPad
Table 1 diet composition in KEMEPHY (ketogenic Mediterranean with phytoextracts) diet.
KEMEPHY Week 1-3 KEMEPHY Week 4-6
Energy Kcal 1098 ± 21.3 1186 ± 107
Protein, g/day
(% daily Energy)
99 (36) 91 (31)
Carbohydrate, g/day (% daily Energy) 34 (12) 74 (25)
Fat, g/day
(% daily Energy)
63 (52) 58 (44)
Mean Kcal/die of the two phases of KEMEPHY 1146 ± 88.8
Kcal values are expressed in mean per day and SD. Other values are expressed in mean per day.
Table 2 Plant extracts used in KEMEPHY (ketogenic Mediterranean with phytoextracts) diet
Plant extracts Week
1-3
Week
4-6
Composition
Extracts A, ml/
day
20 20 Durvillea antarctica, black radish, mint, liquorice, artichoke, horsetail, burdock, dandelion, rhubarb, gentian,
lemon balm, chinaroot, juniper, spear grass, elder, fucus, anise, parsley, bearberry, horehound
Extracts B, ml/
day
20 20 Serenoa, Red clover, Chervil, Bean, Elder, Dandelion, Uncaria, Equisetum, Horehound, Rosemary
Extracts C, ml/
day
50 50 Horsetail, asparagus, birch, cypress, couch grass, corn, dandelion, grape, fennel, elder, rosehip, anise
Extracts D, ml/
day
(only weeks 1
and 2)
40 0 Eleuthero, eurycoma longifolia, ginseng, corn, miura puama, grape, guaranà, arabic coffee, ginger
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expressed as mean ± standard deviation.
Results
Of the 106 persons recruited 87 completed the study
(83, 6% compliance). Of the 19 subjects that withdrew 4
were for family/personal reasons, 8 subjects were lost to
follow up and only 7 withdrew due to inadequate com-
pliance to the diet protocol. Adjusted for causes of
withdrawal only 7 of 104 were not able to follow the
KEMEPHY diet for an adjusted compliance of 93.4%
Blood analysis did not reveal significant modification in
ALT, AST, GGT and bilirubin values, nor were there sig-
nificant variations in creatinine, uric acid, nitrogen and
electrolytes (NA, K, Cl, Ca, Mg). There were significant
changes in lipid profiles with reductions in triglycerides,
total cholesterol and LDL along with a rise in HDL levels
which all reached significance - see Table 4 and 5.
Table 3 Main actives ingredients of used phytoextracts, their reported beneficial effects and related references
Extract Main Active ingredients Reported beneficial effects Refs
A Mint
black radish
burdock
- indigestion
- antioxidant
- choleretic, increases bile secretion helping digestion
[69]
[70]
B Serenoa Repens (saw
palmetto)
hormonal regulating effects [71]
White bean alpha-amylase inhibitory properties and has been reported to aid weight loss and glycemic control [72]
[73]
C Equisetum Antioxidant
diuretic
glycemic control
[74]
[75]
Dandelion (Taraxacum
officinale
diuretic [76]
D Ginseng
Miura Puama
Guaranà
Ameliorate the commonly reported symptoms of weakness and tiredness during the 1
st phase of
ketosis (1/2 weeks)
[77]
[78]
[79]
Figure 1 Experimental design.
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revealed an average weight loss of 6.72 kg or 7.8% (pre
86.15 ± 16.38 vs post 79.43 ± 15.31; p < 0.0001). Fat
mass was reduced from 41.24 ± 6.74 to 34.99 ± 6.74, a
fall of 15.1% (p < 0.0001). As in previous studies no sig-
nificant differences were observed in total body water
expressed as percent of body weight [22,27]. Waist cir-
cumference was reduced by an average of 9.46 cm from
106.56 ± 15.38 to 97.10 ± 12.69, a fall of 8.9% (p <
0.0001). There were also significant reductions in hip
and thigh circumferences of 7.41 cm (from 115 ± 11.24
to 107.78 ± 10.39; p < 0.0001) and 3.32 cm respectively
(from 58.65 ± 5.43 to 55.32 ± 4.90). Anthropometric
and body composition results are showed in tables 6.
Discussion
Many weight loss diet procedures continue to focus on
the reduction of fat content and controlled protein
intake, however our results appear to demonstrate that
the KEMEPHY diet, which is a modification of the
VLCKD, is effective not only for weight and fat loss but
also leads to improvements in the values of various bio-
markers which are associated with increased risk of
metabolic and cardiovascular disease. The weight loss
effect of VLCKD diets may be caused by several factors:
Table 4 Blood biomarker, anthropometric and body composition values, separated for male and female, before and
after 6 weeks KEMEPHY diet. Values are expressed in mean and SD.
Pre diet female Post diet female Pre diet
male
Post diet
male
BUN (mg/dl) 33.4 ± 9.5 33.2 ± 8.7 35.2 ± 6.0 33.8 ± 7.0
Uric acid (mg/dl) 5.0 ± 1.3 5 ± 1.2 4.8 ± 1.3 5.0 ± 1.3
VES (mm/hour) 14 ± 7.3 12.7 ± 7.6 16 ± 7.3 14.4 ± 6.3
Creatinine (mg/dL) 0.84 ± 0.15 0.77 ± 0.11 0.83 ± 0.2 0.85 ± 0.2
Total Cholesterol (mg/dl) 206.2 ± 41.4 182.8 ± 34.3 199.2 ± 29.8 176.9 ± 26.1
HDLc (mg/dl) 46.7 ± 7.2 52.6 ± 9.5 43.9 ± 8.5 50.1 ± 9.1
LDLc (mg/dl) 151.8 ± 28.3 137.1 ± 24.8 140.9 ± 32.9 130.4 ± 25.9
TG (mg/dl) 119.9 ± 60.3 94.2 ± 41.8 114.1 ± 61.8 93.9 ± 46.2
ALT (U/l) 20.5 ± 10.9 17.3 ± 5.1 18.4 ± 4.6 19.1 ± 6.8
AST (U/l) 18.5 ± 5.4 17.1 ± 4.7 17.8 ± 3.8 17 ± 5.1
GGT (U/l) 20.5 ± 10.9 17.3 ± 5.1 21.5 ± 11.7 15.4 ± 4.1
Glucose (mg/dl) 95.7 ± 12.5 90.5 ± 9.8 95.9 ± 11.2 90.6 ± 8
Weight Kg 82.6 ± 12.7 76.3 ± 12.1 102.4 ± 22.2 93.4 ± 21
BMI (Kg/m
2) 31 ± 4.8 28.7 ± 4.6 33.6 ± 6.2 30.6 ± 5.8
% Fat 42.3 ± 6, 8 36 ± 6, 9 37 ± 4.3 30.6 ± 4.1
Waist circumference cm 103.5 ± 14 94, 3 ± 10.3 120.8 ± 15.1 109.7 ± 14.1
Hip circumference cm 114.9 ± 11.6 107.2 ± 10.5 117.3 ± 9.9 111.2 ± 10.4
Table 5 Blood biomarker values (all subjects) before and
after the 6 week KEMEPHY diet. Values are expressed in
mean and SD.
Pre KEMEPHY
diet
Post KEMEPHY
diets
p
BUN (mg/dl) 33.8 ± 8.9 33.4 ± 8.4 n.s.
Uric acid (mg/dl) 4.9 ± 1.3 5 ± 1.2 n.s.
VES (mm/hour) 14.2 ± 7.2 12.8 ± 7.4 n.s.
Creatinine (mg/dL) 0.83 ± 0.16 0.78 ± 0.13 n.s.
Total Cholesterol
(mg/dl)
204.2 ± 40 181.1 ± 33.4 P < 0.0001
HDLc (mg/dl) 46.2 ± 7.4 52.1 ± 7.4 P < 0.0001
LDLc (mg/dl) 149.7 ± 29.1 135.8 ± 24.8 P < 0.0001
TG (mg/dl) 118.6 ± 59.9 93.8 ± 42.2 P < 0.0001
ALT (U/l) 20.7 ± 9.1 18.2 ± 6.7 n.s.
AST (U/l) 18.4 ± 5.1 17 ± 5 n.s.
GGT (U/l) 21 ± 11 17 ± 5 n.s.
Glucose (mg/dl) 96 ± 12 91 ± 9 P < 0.0001
Table 6 Anthropometric and body composition measures
(all subjects) pre and post diet
Pre KEMEPHY
diet
Post KEMEPHY
diets
p
BMI (Kg/m
2) 31.5 ± 5.1 29. ± 4.8 P < 0.0001
Weight Kg 86.2 ± 16.4 79.4 ± 15.3 P < 0.0001
% Fat 41.2 ± 6.7 35 ± 6.7 P < 0.0001
Waist
circumference cm
106.6 ± 15.4 97.1 ± 12.7 P < 0.0001
Hip circumference
cm
115 ± 11.3 107.8 ± 10.4 P < 0.0001
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tion [28-36] in which also ketone bodies may have a
role [37,38], although the mechanism is not clear
[39];
2. Reduction in lipid synthesis and increased lipolysis
mechanisms [40-44];
3. Reduction in at rest respiratory quotient and
therefore an increase in fat metabolism for energy
use [22,45];
4. Increased metabolic expenditure caused by gluco-
neogenesis and the thermic effect of proteins [46-51]
The beneficial effects on cardiovascular risk factors
involve the reduction of blood triglycerides[17,18,22]
and also the reduction of total and LDL cholesterol
along with a rise in HDL cholesterol [17,18,22,52-54].
Furthermore the VLCKD can cause modifications in
LDL-C particles leading to increased size [53] which
may reduce cardiovascular risk since smaller LDL parti-
cles have been shown to be more atherogenic [55].
The cholesterol lowering effect of VLCKD is also
mediated by the well known facilitating action of insulin
on HMGCoA reductase and inhibition of the latter by
cholesterol and fats [56]. Insulin then increases the pro-
duction of endogenous cholesterol while exogenous cho-
lesterol has the opposite effect [56].
The KEMEPHY diet protocol used in this study main-
tains some advantages of the Mediterranean diet such as
the use of olive oil [21] and some vegetables [19]
(selected to avoid stimulating insulin production) but at
t h es a m et i m eb yi n d u c i n gap h y s i o l o g i c a lk e t o s i s[ 5 7 ]
promotes beneficial modifications in cardiovascular risk
factors and body composition [22]. The use of the
phyoextracts in this study may have contributed to the
absence of commonly reported mild effects of ketosis (e.
g. weakness, constipation, bad breath, headache). During
the first three weeks of the KEMEPHY diet subjects
avoided fructose completely and during the second
three weeks only a moderate amount of fructose, exclu-
sively from fruit, and therefore together with starch, was
permitted. As a matter of fact fructose may stimulate fat
biosynthesis via mechanisms which are not yet fully
characterised [58], also several studies have reported
that excessive concentrations of fructose can induce
some or all of the features of metabolic syndrome inde-
pendently of energy intake. Clinical and epidemiologic
data further suggest that excessive fructose intake can
contribute to the causes of metabolic syndrome [59].
Adjusted compliance in this study was 93.4% which is
higher than reported compliances of standard VLCK
diets (in the 20% to 58% range). [22,60,61]. It is tempt-
ing to speculate that the inclusion of “carbohydrate-like”
formulated foods is one of the reasons for high compli-
ance - however this, along with the potential benefits of
the phytoextracts, requires further verification in a
future study with a matched control group.
Safety considerations
If we assimilate de facto, which is not always correct,
ketogenic diets with high protein diets then the risks
proposed by critics of this type of dietary approach are
essentially those of possible kidney damage due to high
levels of nitrogen excretion during protein metabolism
which can cause an increase in glomerular pressure and
hyper-filtration [27]. There is not wide agreement
between studies however, some infer the possibility of
renal damage from animal studies [62,63] while others,
looking at both animal models and human studies pro-
pose that even high levels of protein in the diet do not
damage renal function [64,65]. In subjects with intact
renal function higher dietary protein levels caused some
functional and morphological adaptations without nega-
tive effects [66]. Also it should be underlined that keto-
genic diets are only relatively high in protein [49,67]
and that some recent studies have demonstrated that
VLCKD can even cause a regression of diabetic nephro-
pathy in mice [68]. With regard to possible acidosis dur-
ing VLCKD since the concentration of ketone bodies
never rises above 8 mmol/l [40,42] this risk is virtually
inexistent in subjects with healthy insulin function.
Conclusions
Some limitations to this study include the lack of a
matched control group and the short trial period. There
are though many studies that demonstrate that VLCK
diets are more effective than low fat or standard Medi-
terranean diets, at least over the short term [21], and
the main aims of the present initial study were to assess
safety aspects, acceptance & palatability and weight loss
& biomarker changes. We are able to conclude that at
least in the short term it was able to lead to positive
changes including the reduction of fasting blood glu-
cose, improvements in lipid profiles, significant and
rapid weight and fat loss with the preservation of lean
m a s s .W ea l s on o t eah i g hl e v e lo fc o m p l i a n c e ,w h e t h e r
this was due to specific unique features of the present
diet requires confirmation in a future matched control
trial.
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